Company: ECIA
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001079973-25-001132
Chunk: 18

Company: ENCISION INC
Filing Date: 2025-07-10
Form: 10-K
Item: Item 1
Chunk 18
---
 customer bases in the medical products market and have significantly greater market recognition
than we have. As a result of these factors, our competitors may be able to respond more quickly to new or emerging technologies and changes
in customer requirements or to devote greater resources to the development, promotion and sale of their products. It is possible that
new competitors or new alliances among competitors may emerge and rapidly acquire significant market share. The competitive pressures
we face may materially adversely affect our financial position, results of operations and cash flows, and this may hinder our ability
to respond to competitive threats.

If we do not continually enhance our products
and keep pace with rapid technological changes, we may not be able to attract and retain customers. Our future success and financial
performance will depend in part on our ability to meet the increasingly sophisticated needs of customers through the timely development
and successful introduction of product upgrades, enhancements and new products. These upgrades, enhancements and new products are subject
to significant technological risks. The medical device market is subject to rapid technological change, resulting in frequent new product
introductions and enhancements of existing products, as well as the risk of product obsolescence. While we are currently developing new
products and enhancing our existing product lines, we may not be successful in completing the development of new products or enhancements.
In addition, we must respond effectively to technological changes by continuing to enhance our existing products to incorporate emerging
or evolving standards. We may not be successful in developing and marketing product enhancements or new products that respond to technological
changes or evolving industry standards. We may experience difficulties that could delay or prevent the successful development, introduction
and marketing of those products, and our new products and product enhancements may not adequately meet the requirements of the marketplace
and achieve commercially viable levels of market acceptance. If any potential new products, upgrades, or enhancements are delayed, or
if any potential new products, upgrades, or enhancements experience quality problems or do not achieve market acceptance, or if new products
make our existing products obsolete, our financial position, results of operations and cash flows would be materially adversely affected.

11 

If government regulations change or if we
fail to comply with existing and/or new regulations, we might miss market opportunities and experience increased costs and limited growth.
The research, development, manufacturing, marketing and distribution of our products in the United States and other countries are
subject to extensive regulation by numerous governmental authorities including, but not limited to, the Food and Drug Administration.
Under the Federal Food, Drug and Cosmetic Act, medical